Simon N Young1, Marjan Shalchi. 1. Department of Psychiatry, McGill University, Montréal, QC. simon.young@mcgill.ca
Abstract
OBJECTIVE: S-Adenosylmethionine (SAMe) is a major methyl donor in the brain and is also an antidepressant with few reported side effects; however, SAMe is relatively expensive and unstable. Brain SAMe can be increased by giving methionine to rats, raising the possibility that methionine may be an antidepressant. We aimed to study whether SAMe and methionine, when given orally to rats, could raise levels of SAMe in the central nervous system (CNS). We also aimed to test the relative abilities of SAMe and methionine to increase tail-flick latency after a thermal stimulus. This test was used to measure changes in CNS function. METHODS: Rats were given SAMe and methionine orally at various doses, and biochemical and behavioural testing was carried out at intervals up to 6 hours later. RESULTS: Methionine raised SAMe levels in various regions of the CNS and increased tail-flick latency, both at lower doses than SAMe. CONCLUSION: Methionine should be tested for antidepressant properties in humans.
OBJECTIVE:S-Adenosylmethionine (SAMe) is a major methyl donor in the brain and is also an antidepressant with few reported side effects; however, SAMe is relatively expensive and unstable. Brain SAMe can be increased by giving methionine to rats, raising the possibility that methionine may be an antidepressant. We aimed to study whether SAMe and methionine, when given orally to rats, could raise levels of SAMe in the central nervous system (CNS). We also aimed to test the relative abilities of SAMe and methionine to increase tail-flick latency after a thermal stimulus. This test was used to measure changes in CNS function. METHODS:Rats were given SAMe and methionine orally at various doses, and biochemical and behavioural testing was carried out at intervals up to 6 hours later. RESULTS:Methionine raised SAMe levels in various regions of the CNS and increased tail-flick latency, both at lower doses than SAMe. CONCLUSION:Methionine should be tested for antidepressant properties in humans.
Authors: T Bottiglieri; M Laundy; R Crellin; B K Toone; M W Carney; E H Reynolds Journal: J Neurol Neurosurg Psychiatry Date: 2000-08 Impact factor: 10.154
Authors: Katherine N Wright; Fiona Hollis; Florian Duclot; Amanda M Dossat; Caroline E Strong; T Chase Francis; Roger Mercer; Jian Feng; David M Dietz; Mary Kay Lobo; Eric J Nestler; Mohamed Kabbaj Journal: J Neurosci Date: 2015-06-10 Impact factor: 6.167
Authors: Riya R Kanherkar; Susan E Stair; Naina Bhatia-Dey; Paul J Mills; Deepak Chopra; Antonei B Csoka Journal: Evid Based Complement Alternat Med Date: 2017-02-21 Impact factor: 2.629
Authors: Avinash Kumar; Rashmi Pathak; Henry A Palfrey; Kirsten P Stone; Thomas W Gettys; Subramanyam N Murthy Journal: Nutr Metab (Lond) Date: 2020-01-06 Impact factor: 4.169
Authors: Vanessa Hübner; Luciana Hannibal; Nils Janzen; Sarah Catharina Grünert; Peter Freisinger Journal: Genes (Basel) Date: 2022-06-27 Impact factor: 4.141